4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-22-000018
Chief Operating Officer sold 1,777 shares at an average $15.11 ($26,845)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J Chief Operating Officer | 2022-09-08 | Sale | −912 | $15.15 | $13,814 | 69,613 | D |
| Dowden Nathan J Chief Operating Officer | 2022-09-09 | Sale | −865 | $15.06 | $13,031 | 68,748 | D |
| Open-market sales · 1,777 sh · avg $15.11 · $26,845 | |||||||
Loading xslF345X03/wf-form4_166301365870769.xml…